Ai-driven innovation for the nutraceutical industry
Nutraceutical and supplement development faces challenges like inefficient testing, high financial risks, regulatory hurdles, and market competition.
Our AI-powered platform uses mechanistic pathway modeling to predict efficacy and bioavailability, identify synergistic effects and potential risks, and streamline regulatory compliance, reducing development costs and accelerating time to market.
Explore key features
Explore MedXP Lab's core capabilities: mechanistic pathway analysis, synergy simulation, risk alerts, AI report generation, and customized deployment options.
Mechanistic pathway analysis
Utilizes mechanistic pathway modeling to predict biological effects.
Synergy simulation engine
Simulates ingredient synergy.
Risk & interaction alerts
Identifies potential risks and interactions.
Ai-powered report builder
Generates reports using AI.
Custom deployment options
Offers flexible deployment choices.
Review our progress
Accelerating innovation through AI-driven simulation
This AI-powered platform simulates supplement and nutraceutical innovation, predicting biological effects and risks before clinical trials.
It's designed for formulators, CROs, and research labs, reducing R&D costs and accelerating time to market.
The platform supports regulatory compliance and is trusted by medical professionals and intellectual property holders.
Get your questions answered
Pricing is determined by subscription tiers offering varying levels of access and functionality. Contact us for a customized quote.
The platform can simulate a wide range of supplements and nutraceuticals, including vitamins, minerals, herbs, botanicals, and other bioactive compounds.
The AI's accuracy is based on the mechanistic pathway modeling (MPAS) and the quality of input data.
The platform uses MPAS to model the interaction of ingredients within biological pathways.
Hear from our clients
MedXP Lab significantly reduced our R&D time by accurately predicting ingredient interactions, saving us valuable resources and accelerating our product launch.
Client A
Formulator
The platform's accuracy in predicting biological effects has been remarkable. It's allowed us to make informed decisions early in the development process, minimizing costly mistakes.
Client B
CRO Scientist
MedXP Lab's mechanistic pathway modeling has been instrumental in streamlining our research. The insights gained have greatly improved the efficiency of our R&D process.
Client C
Research Scientist
We've been impressed by the platform's ability to identify potential risks before manufacturing.
Client D
Regulatory Affairs Specialist
MedXP Lab: AI-powered simulation for supplement and nutraceutical innovation.